The official advocacy organization for pharmacist women in the United States
Pharmacist Moms Group™
45,000+ Members
Over 6 Million posts, comments and reactions in 2020
60,000+ Followers on social media platforms
The Largest Community of Women Pharmacists in the US
Founded in 2017, Pharmacists Moms Group was created to provide women pharmacists the opportunity to network, collaborate and offer genuine feedback in a closed-door, trusted setting. The organization has quickly grown to over 45,000 members and 60,000 followers on our social media platforms.
While we may not be able to control what happens to us, we can ALWAYS control how we respond. Working on self-awareness and self-improvement will certainly create positive habits to help you when you are stuck.
Read on to learn more about Jennifer’s path to pharmacy ownership, and to learn how COVID-19 and the Oregon wildfires have impacted her business.
Miss America 2020, Camille Schrier, has been a proud, self-described “science nerd” for as long as she can remember. We caught up with Camille to get a student’s perspective on the future of the profession.
Predictive scheduling can improve staffing, pharmacy preparation, infusion capacity, and the overall patient experience.
July 2026 brought advances in nonopioid drug development, opioid stewardship, procedural analgesia, cancer pain, pediatric medication safety, and understanding the genetic basis of fibromyalgia.
July 2026 brought major hematology advances in gene therapy, transplantation, targeted treatments, and bleeding disorder care, alongside notable clinical trial setbacks.
This roundup highlights 5 key solid tumor updates from July 2026, including new FDA approvals across bladder, breast, and lung cancers, a tissue-agnostic targeted therapy, and a blood-based colorectal cancer screening test.
CVS pharmacists expand into frontline care, guiding immunizations, birth control prescribing, and at-home tests like UTIs and fertility to steer patients toward timely, cost-effective treatment.
The phase 2 AZTEC trial found that single- and multi-fraction SABR followed by atezolizumab had similar safety and limited efficacy in advanced TNBC.
Official Media Partner
.png)
Official CE Partner
Founder of Women Pharmacist Day
